IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Viridian Therapeutics Inc

CUSIP: 92790CAB0 | 27 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Context Capital Management, LLC49,000,000
1.2% of portfolio›$56.5M
Acasta Partners UK LLP5,000,000
2.6% of portfolio›$5.7M
Jefferies Financial Group Inc.3,560,000
0.0% of portfolio›$4.1M
StyleTurnoverLocationFiled
Context Capital Management, LLC
49,000,000$56.5M1.2%GARPHighGreenwich, CT2026-11-04
Acasta Partners UK LLP
5,000,000$5.7M2.6%Deep ValueHighLondon, United Kingdom2026-10-05
Jefferies Financial Group Inc.
3,560,000$4.1M0.0%CoreVery HighNew York, NY2026-11-05